Brief: Seres Therapeutics Q2 EPS USD 0.47
05/08/2026 12:01
BRIEF-Seres Therapeutics Q2 EPS USD 0.47 Aug 05 (Reuters) - Seres Therapeutics Q2 operating income USD -21.273 million.
- Q2 operating expenses USD 22.009 million
- Q2 collaboration revenue USD 736 thousand
- Q2 net income USD 4.581 million
Recent news on Seres Therapeutics
See all newsChinese automakers make tech-led pitch for Europe's premium car market
Brief: Seres Therapeutics - May Offer Up To $300 Million Of Securities
Seres Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Seres Therapeutics Q2 net income turns positive on VOWST sale gain
Brief: Seres Therapeutics Q2 EPS USD 0.47